National Institute for Health and Clinical Excellence.NICE technology appraisal guidance 151. Continuous subcutaneous insulin infusion for the treatment of diabetes mellitus (review of technology appraisal guidance 57). London: National Institute for Health and Clinical Excellence, July 2008. http://www.nice.org.uk/TA151 (Accessed 23 July 2008).
2.
Kerr D.Continuous subcutaneous insulin infusion therapy and children with type 1 diabetes mellitus: the 2008 updated NICE guidelines. Br J Diabetes Vasc Dis2008; 8:(Suppl 1): S2-5
3.
Campbell F.The pros and cons of continuous subcutaneous insulin infusion (CSII) therapy in the paediatric population and practical considerations when choosing and initiating CSII in children. Br J Diabetes Vasc Dis2008; 8:(Suppl 1): S6-10
4.
Hammond P.Use of continuous subcutaneous insulin infusion in special populations and circumstances in patients with type 1 diabetes. Br J Diabetes Vasc Dis2008; 8:(Suppl 1): S11-14
